glp 1 banned GLP-1 weight-loss drugs are a hot topic when it comes to health. Now, critics are debating whether the medications should be in sports for potentially being a performance-enhancing drug Critics are debating whether GLP-1
Description
Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.

Sandoz CEO Richard Saynor describes Canada as the world's second-largest GLP-1 market, raising cross-border supply concerns as generics near approval.
PROMOTE HEALTHY FAT LOSS

Learn about eligibility, deadlines, and how to file a claim.
However, few research has explored its role o...
